Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Markqayne D Ray"'
Autor:
Olalekan O. Oluwole, Markqayne D. Ray, Richard M. Zur, Cheryl P. Ferrufino, Brett Doble, Anik R. Patel, S. Pinar Bilir
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionNovel therapies for 3L+ relapsed/refractory (r/r) follicular lymphoma (FL) have been approved recently by the US Food and Drug Administration including anti-CD19 CAR-T therapies such as axicabtagene ciloleucel (axi-cel) and CD20 × CD3 T-
Externí odkaz:
https://doaj.org/article/0bf9658a2eb640f7b7c7528ac49a045b
Autor:
Frederick L. Locke, Sattva S. Neelapu, Markqayne D. Ray, Eve H Limbrick-Oldfield, Sally W Wade, Steve Kanters, Anik R. Patel, Olalekan O. Oluwole
Publikováno v:
Blood. 140:7516-7518
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55d20b3debfe661fdfbc38f4a1acc10e
https://doi.org/10.1182/blood-2022-169812
https://doi.org/10.1182/blood-2022-169812
Autor:
Olalekan O. Oluwole, Markqayne D. Ray, Katherine L. Rosettie, Graeme Ball, Jorge Jacob, Pinar Bilir, Anik R. Patel, Caron A. Jacobson
Publikováno v:
Blood. 140:10822-10824
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abbb3a7a98ad6c629886058b442ff898
https://doi.org/10.1182/blood-2022-163789
https://doi.org/10.1182/blood-2022-163789
Autor:
M Lia Palomba, Paola Ghione, Anik R Patel, Myrna Nahas, Sara Beygi, Anthony J Hatswell, Steve Kanters, Eve H. Limbrick-Oldfield, Sally W Wade, Markqayne D Ray, Jessica Owen, Sattva S Neelapu, John Gribben, John Radford, Sabela Bobillo
Publikováno v:
Palomba, M L, Ghione, P, Patel, A R, Nahas, M, Beygi, S, Hatswell, A J, Kanters, S, Limbrick-Oldfield, E H, Wade, S W, Ray, M D, Owen, J, Neelapu, S S, Gribben, J, Radford, J & Bobillo, S 2023, ' A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma ', Expert Review of Anticancer Therapy, vol. 23, no. 2, pp. 199-206 . https://doi.org/10.1080/14737140.2023.2171994
Scientia
Scientia
Follicular lymphoma; Axicabtagene ciloleucel; Comparative effectiveness Limfoma fol·licular; Axicabtagene ciloleucel; Eficàcia comparativa Linfoma folicular; Axicabtagene ciloleucel; Eficacia comparativa Background In the ZUMA-5 trial (Clinical tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d727090bb434c68e1185c778daaf38
Autor:
Paola Ghione, Maria Lia Palomba, Markqayne D. Ray, Eve H. Limbrick-Oldfield, Jess Owen, Steve Kanters, Sabela Bobillo, Maria Teresa Ribeiro, Caron A. Jacobson, Sattva S. Neelapu, Herve Ghesquieres, Myrna Nahas, Sara Beygi, Anik R. Patel, John G. Gribben
Publikováno v:
Blood. 140:4676-4677
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27075ad21a5ca3cdad06a1af869a00f3
https://doi.org/10.1182/blood-2022-170469
https://doi.org/10.1182/blood-2022-170469